tirzepatide landmark trial for masld A phase 3 reported in Nature Medicine shows weekly subcutaneous injections of survodutide, a glucagon receptor/GLP-1R dual agonist, lowered liver fat content and body weight in adults with obesity and at-risk Guideline-directed medical strategies for the

While these can reduce inflammation, they often bring difficult side effects: Weight gain, bloating, and bone loss Increased infection risk Fatigue and mood changes High long-term costs Because these drugs suppress the immune system instead of balancing it, flare-ups frequently return once treatment stops

While the wireless sound of these headphones is impeccable, its also possible to listen to the Crossfade 3 using a cable connection for even higher-resolution audio

And that raises questions about whether patients who might benefit and are interested will even be able to afford them

For many patients with obesity or diabetes, the benefits may be significant

Turner D, Levine A, Kolho KL, Shaoul R, Ledder O

doi: 10.1016/j.celrep.2016.07.027